IAS
FATE icon

IMA Advisory Services’s Fate Therapeutics FATE Stock Holding History

IMA Advisory Services’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-39
Closed -$1K – 383
2022
Q3 		$1K Hold
39
– – ﹤0.01% 309
2022
Q2 		$1K Sell
39
-23,483
-100% -$648K ﹤0.01% 312
2022
Q1 		$912K Buy
23,522
+7,684
+49% +$298K 0.21% 89
2021
Q4 		$927K Buy
+15,838
New +$898K 0.2% 90

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

IMA Advisory Services's FATE Position: Q4 2022 in Review

IMA Advisory Services sold out of Fate Therapeutics (FATE) in Q4 2022, closing a stake of 39 shares — an estimated $1K sold.

IMA Advisory Services first reported a position in FATE in Q4 2021 and held it in 4 quarters. The position peaked at $927K in Q4 2021. 227 funds tracked by Wall St. Rank hold FATE as of Q4 2022.

  • IMA Advisory Services reported no remaining Fate Therapeutics position as of Q4 2022 after selling out during the quarter.
  • IMA Advisory Services sold 39 Fate Therapeutics shares in Q4 2022, an estimated $1K.
  • IMA Advisory Services first reported a position in Fate Therapeutics in Q4 2021 and held it in 4 quarters.
  • IMA Advisory Services's Fate Therapeutics position peaked at $927K in Q4 2021.
  • 227 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2022.

Based on IMA Advisory Services's 13F filing for Q4 2022, filed 16 Feb 2023.